|Videos|September 2, 2021
42-Year-Old Female With Itchy Eyes
This program is sponsored by Eyevance Pharmaceuticals, a Santen company.
Advertisement
Mark S. Milner, MD
Board-certified Ophthalmologist
Associate Clinical Professor, Yale University School of Medicine,
New Haven, Connecticut
Director of Cornea, Goldman Eye, Palm Beach Gardens, Florida
Co-Chief Medical Officer, Eyevance Pharmaceuticals, a Santen company
Advertisement
Related to this article
A comparison of ETDRS charts using Latin letters, Tumbling E, and Landolt C optotypes found the alternatives are comparable to letter acuity at the population level.
Vision testing results from 384 public transport drivers in Mumbai found the Visiolite 4K screener accurately matched standard assessments while cutting screening time by 65%.
In the latest episode of The Independent Advantage, Maria Sampalis, OD, gives a resounding "absolutely not" when posited with the question of whether or not eye care providers will be replaced by AI.
A recent study found that migraines were associated with higher adverse vision outcomes in a cohort of Norwegian adolescents.
Jem Martin, OD, discusses the accommodations and referrals any provider can offer, the red flags that should raise suspicion of CVI, and how the free TEACHCVI screening tool works in practice.
AMA resolution backs classifying myopia as a disease, aiming to expand insurance coverage for pediatric myopia control treatments.
Optometrists should know what is expected, what is concerning, and when to contact the surgeon.
Catch up on the top stories in optometry during the week of September 7-September 11.
Advertisement
Advertisement